Navigation Links
Memory Clinics are Diverting NHS Resources from High Quality Care

Specialist memory clinics for patients with dementia are taking NHS resources away from long term integrated care, warn senior doctors in this week’s BMJ.//

Since 2001, the National Institute for Health and Clinical Excellence (NICE) has recommended that cholinesterase inhibitors should be available to people with mild to moderate Alzheimer’s disease, writes consultant psychiatrist, Anthony Pelosi and colleagues.

This was based on evidence that these drugs slowed cognitive (mental) decline, but NICE stressed that further research was required and it planned to revisit its recommendations after several years.

The guidelines were welcomed by patient and carer organisations, and a large number of specialist memory clinics were set up for the prescription and monitoring of these medicines, sometimes with funding from the drug manufacturers.

But widespread clinics have distorted clinical priorities, argue the authors. They have recruited full multidisciplinary teams while there is a shortage of mental health professionals throughout the United Kingdom, and they do not offer care in the community to their patients as they decline. Patients then have to be referred to ordinary old age psychiatry teams, which have to arrange proper long-term management plans.

Further research is now available and shows quite consistently that these medicines have modest beneficial effects compared with placebo. As a result, NICE recommended that the NHS should no longer prescribe cholinesterase inhibitors because they do not provide value for money.

But after hostile reactions from clinicians, patients and carers, with support from the lay media, NICE now proposes restricting use to moderate Alzheimer’s disease. But doctors are concerned that it will be extremely difficult (perhaps impossible) to wait for a diagnosed patient to deteriorate before starting treatment.

NICE has been unfairly accused of ageism a nd stigmatisation of people with dementia, and it has been claimed that adoption of the revised guidelines would be devastating for patients and carers. But the tragedy is not the proposed restrictions, but the fact that the only currently licensed medicines for a cruel illness have turned out to be of marginal benefit, write the authors.

Whatever the final outcome of NICE’s deliberations, the human and financial resources that have become tied up in clinics organised around prescription of cholinesterase inhibitors must be diverted to old age psychiatry teams and their social care counterparts, they say.

These medicines should no longer be allowed to have such influence on services for patients with Alzheimer’s disease and their families.


Related medicine news :

1. Memory problem? solve a crossword
2. Deep Sleep Doesnt Increase Memory
3. For a Better Memory
4. Memory loss associated with microbes
5. Memory loss always goes hand with Depression
6. Memory deprivation after operations
7. Sage Improves Memory
8. Memory said to automatically improve with age
9. Enzyme Associated with Memory
10. Enzyme Associated With Memory
11. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
Post Your Comments:

(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
(Date:6/23/2016)...  Guerbet announced today that it has been named ... . One of 12 suppliers to receive ... support of Premier members through exceptional local customer service ... to lower costs. ... outstanding customer service from Premier," says Massimo Carrara ...
Breaking Medicine Technology: